World Journal of Neuroscience
Vol.8 No.2(2018), Paper ID 84358, 14
pages
DOI:10.4236/wjns.2018.82014
Long-Term Monoacylglycerol Lipase Inhibitor Treatment Decelerates Pathological Changes in APP/PS1-21 Mice, but Behavioral Improvements Require Early-Stage Treatment Onset—Short Report
Rea Pihlaja, Noora Lindgren, Annamari Torittu, Anniina Snellman, Merja Haaparanta-Solin, Juha O. Rinne
PET Preclinical Laboratory, Turku PET Centre, University of Turku, Turku, Finland
Turku PET Centre, Turku University Hospital, Turku, Finland
Department of Biochemistry, University of Turku, Turku, Finland
Medicity Research Laboratory, University of Turku, Turku, Finland
PET Preclinical Laboratory, Turku PET Centre, University of Turku, Turku, Finland
Division of Clinical Neurosciences, Turku University Hospital, Turku, Finland
Copyright © 2018 Rea Pihlaja, Noora Lindgren, Annamari Torittu, Anniina Snellman, Merja Haaparanta-Solin, Juha O. Rinne et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Pihlaja, R. , Lindgren, N. , Torittu, A. , Snellman, A. , Haaparanta-Solin, M. and Rinne, J. (2018) Long-Term Monoacylglycerol Lipase Inhibitor Treatment Decelerates Pathological Changes in APP/PS1-21 Mice, but Behavioral Improvements Require Early-Stage Treatment Onset—Short Report.
World Journal of Neuroscience,
8, 157-170. doi:
10.4236/wjns.2018.82014.